| abstract |
Disclosed is a compound represented by general formula (II) or a salt thereof, which is a GPR119 agonist and to be used as a therapeutic agent for diabetes. In general formula (II), R 23 , R 24 and R 25 represent a hydrogen atom, a halogen atom, a C 1-8 alkyl group, a C 1-8 alkoxy group, a C 1-8 alkylsulfonyl group, etc.; Q 0 and T 0 represent CH 2 , etc., or Q 0 and T 0 together form CH=CH, etc.; A 0 represents (CH 2 ) p , C(O) or a bond; B 0 represents a bond, etc.; one of U 0 and V 0 represents N and the other represents CR 31 , etc.; X 0 and Y 0 represent CH 2 CH 2 , etc.; Z 0 represents C(O)OR 32 , etc.; and R 21 and R 22 represent a hydrogen atom, a halogen atom, a C 1-8 alkyl group, etc. |